Breast Cancer Blood Test Introduced to the Middle East

The most prevalent cancer among women, breast cancer affects approximately 1.2 million women worldwide. While millions of American women receive mammography screenings each year, many women in the Middle East avoid this important screening procedure, often because of strong underlying cultural bias.

"Fully 70% of worldwide breast cancer cases occur in developing countries," says Dr. Essam Sheta, a researcher at Power3 Medical Products, Inc. (OTCBB: PWRM), a company specializing in the development and commercialization of diagnostic tests for the early detection of breast cancer and neurodegenerative diseases. "Lack of early detection and diagnosis is the basis for this high incidence rate. While in the U.S., doctors use mammography, ultrasound, and MRI to diagnosis women with breast cancer, these procedures are available, but scarce in developing countries."

read article at centredaily.com